Ignite Creation Date:
2024-05-06 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04686591
Status:
COMPLETED
Last Update Posted:
2021-03-09
First Post:
2020-12-17
Brief Title:
Absolute Bioavailability and ADME Study of 14CAZD9977 in Healthy Male Subjects
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Phase I Open-label Study of Absolute Bioavailability and Absorption-Distribution-Metabolism-Excretion ADME of 14CAZD9977 in Healthy Male Subjects
Status:
COMPLETED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study to Assess the Absorption Metabolism and Excretion of 14CAZD9977 after a Single-Dose Oral Administration
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None